Literature DB >> 20440290

Short-term vascular risk: time to take notice?

Liam Smeeth1, Aroon D Hingorani.   

Abstract

Current guidance around the prevention of cardiovascular events is based on long-term risk, typically calculated over 10 years. A growing body of evidence, however, suggests that vascular risk fluctuates greatly over much shorter time periods. We suggest a new paradigm for cardiovascular risk management that is based on targeting interventions during periods of enhanced risk. During such high-risk time windows, prophylactic therapy could have a disproportionately large absolute benefit, altering the risk-benefit balance and cost-effectiveness of available treatments. Major surgery is an example of an exposure known to lead to a transient increase in vascular risk. Emerging evidence supports the usefulness of short-term preventative interventions in the perioperative period. Influenza infection is another exposure known to increase the risk of vascular events, and cardiovascular mortality and morbidity are likely to be major features associated with pandemic influenza. Important questions remain, however, before preventative interventions can be offered as a routine part of influenza management.

Entities:  

Mesh:

Year:  2010        PMID: 20440290     DOI: 10.1038/nrcardio.2010.64

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  30 in total

1.  Treatment of periodontitis and endothelial function.

Authors:  Maurizio S Tonetti; Francesco D'Aiuto; Luigi Nibali; Ann Donald; Clare Storry; Mohamed Parkar; Jean Suvan; Aroon D Hingorani; Patrick Vallance; John Deanfield
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

2.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

3.  Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.

Authors:  M A Mittleman; M Maclure; G H Tofler; J B Sherwood; R J Goldberg; J E Muller
Journal:  N Engl J Med       Date:  1993-12-02       Impact factor: 91.245

4.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

5.  Cardiovascular events during World Cup soccer.

Authors:  Ute Wilbert-Lampen; David Leistner; Sonja Greven; Tilmann Pohl; Sebastian Sper; Christoph Völker; Denise Güthlin; Andrea Plasse; Andreas Knez; Helmut Küchenhoff; Gerhard Steinbeck
Journal:  N Engl J Med       Date:  2008-01-31       Impact factor: 91.245

6.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

Authors:  Gilles Montalescot; Stephen D Wiviott; Eugene Braunwald; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

7.  Therapy for triggered acute risk prevention: a study of feasibility.

Authors:  Elizabeth Shaw; Geoffrey H Tofler; Thomas Buckley; Beata Bajorek; Michael Ward
Journal:  Heart Lung Circ       Date:  2009-05-01       Impact factor: 2.975

Review 8.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review.

Authors:  Charlotte Warren-Gash; Liam Smeeth; Andrew C Hayward
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

9.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more
  1 in total

1.  Predicting early death in patients with traumatic bleeding: development and validation of prognostic model.

Authors:  Pablo Perel; David Prieto-Merino; Haleema Shakur; Tim Clayton; Fiona Lecky; Omar Bouamra; Rob Russell; Mark Faulkner; Ewout W Steyerberg; Ian Roberts
Journal:  BMJ       Date:  2012-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.